Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113200899A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113200899A details a novel one-pot FeCl3-catalyzed synthesis of aryl selenides, offering high yields and cost reduction in pharmaceutical intermediates manufacturing.